Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sima P Porten

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Current Urology Reports|October 26, 2018
Epigenetic Alterations in Bladder CancerSima P Porten
European Urology Open Science|November 3, 2022
Sex-specific Augmentation of Treatment Responses in Bladder CancerKevin Chang, Sima P Porten
European Urology Focus|September 4, 2022
Which Biomarkers are Useful in the Management of Muscle-invasive Bladder Cancer in 2022?Julie Szymaniak, Sima P Porten
Cancer|July 13, 2019
Optimizing cystectomy outcomesSima P Porten, Viraj A Master
Urology|September 28, 2025
Editorial Comment on "Assessing the Diagnostic Performance of Renal Ultrasound in Microhematuria Evaluation: Validation of the AUA Microhematuria 2020 Guidelines"Meera R Chappidi, Sima P Porten
Current Opinion in Urology|July 31, 2012
High-risk nonmuscle invasive bladder cancer: definition and epidemiologySima P Porten, Matthew R Cooperberg
Translational Andrology and Urology|September 18, 2020
Bladder tumor recurrence after urothelial carcinoma of the upper urinary tractPeter E Lonergan, Sima P Porten
Current Opinion in Urology|June 13, 2014
Variant histology: role in management and prognosis of nonmuscle invasive bladder cancerSima P Porten, Daniel Willis, Ashish M Kamat
Nature Reviews. Urology|February 10, 2011
Prostate cancer: reducing overtreatment: active surveillance in low-risk diseaseJared M Whitson, Sima P Porten, Peter R Carroll
Indian Journal of Urology : IJU : Journal of the Urological Society of India|November 26, 2015
Intravesical chemotherapy in non-muscle-invasive bladder cancerSima P Porten, Michael S Leapman, Kirsten L Greene
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Current Urology Reports|October 26, 2018
Epigenetic Alterations in Bladder CancerSima P Porten
European Urology Open Science|November 3, 2022
Sex-specific Augmentation of Treatment Responses in Bladder CancerKevin Chang, Sima P Porten
European Urology Focus|September 4, 2022
Which Biomarkers are Useful in the Management of Muscle-invasive Bladder Cancer in 2022?Julie Szymaniak, Sima P Porten
Cancer|July 13, 2019
Optimizing cystectomy outcomesSima P Porten, Viraj A Master
Urology|September 28, 2025
Editorial Comment on "Assessing the Diagnostic Performance of Renal Ultrasound in Microhematuria Evaluation: Validation of the AUA Microhematuria 2020 Guidelines"Meera R Chappidi, Sima P Porten
Current Opinion in Urology|July 31, 2012
High-risk nonmuscle invasive bladder cancer: definition and epidemiologySima P Porten, Matthew R Cooperberg
Translational Andrology and Urology|September 18, 2020
Bladder tumor recurrence after urothelial carcinoma of the upper urinary tractPeter E Lonergan, Sima P Porten
Current Opinion in Urology|June 13, 2014
Variant histology: role in management and prognosis of nonmuscle invasive bladder cancerSima P Porten, Daniel Willis, Ashish M Kamat
Nature Reviews. Urology|February 10, 2011
Prostate cancer: reducing overtreatment: active surveillance in low-risk diseaseJared M Whitson, Sima P Porten, Peter R Carroll
Indian Journal of Urology : IJU : Journal of the Urological Society of India|November 26, 2015
Intravesical chemotherapy in non-muscle-invasive bladder cancerSima P Porten, Michael S Leapman, Kirsten L Greene
Pageof 9